| __timestamp | Alpine Immune Sciences, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 504755000 |
| Thursday, January 1, 2015 | 6844000 | 838526000 |
| Friday, January 1, 2016 | 8586000 | 1177697000 |
| Sunday, January 1, 2017 | 6079000 | 1320433000 |
| Monday, January 1, 2018 | 8362000 | 1556200000 |
| Tuesday, January 1, 2019 | 9467000 | 1834800000 |
| Wednesday, January 1, 2020 | 10899000 | 1346000000 |
| Friday, January 1, 2021 | 14560000 | 1824900000 |
| Saturday, January 1, 2022 | 17968000 | 2115900000 |
| Sunday, January 1, 2023 | 22222000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Unleashing insights
In the competitive world of biotechnology, operational efficiency is key. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc. over the past decade. Regeneron, a giant in the industry, has seen its SG&A expenses grow from approximately $500 million in 2014 to over $2.6 billion in 2023, reflecting a fivefold increase. Meanwhile, Alpine Immune Sciences, a smaller player, has experienced a tenfold rise in SG&A expenses, from around $2 million to $22 million in the same period. This stark contrast highlights the scale and growth dynamics of these companies. While Regeneron's expenses are significantly higher, Alpine's rapid percentage increase suggests aggressive expansion efforts. Understanding these trends provides valuable insights into each company's strategic priorities and market positioning.
Johnson & Johnson and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Merck & Co., Inc. or Alpine Immune Sciences, Inc.: Who Manages SG&A Costs Better?
Amgen Inc. and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Neurocrine Biosciences, Inc.
Regeneron Pharmaceuticals, Inc. and Walgreens Boots Alliance, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Grifols, S.A.
Regeneron Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.: SG&A Expense Trends
Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Evotec SE